Restera, Inc.

12 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Invicta Medical, Inc. (to 2026)

Ending by 2030

Mar 2034

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jul 30, 2027
The maintenance fee for Implantable electrodes with remote power delivery for treating sleep apnea, and associated systems and methods (US 11,883,668) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
1 fee due Oct 23, 2027
The maintenance fee for Signal Delivery Devices to Treat Sleep Apnea, and Associated Methods and Systems (US 11,964,154) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 10,195,426	Method and Apparatus for Treating Sleep Apnea In force Term ends Mar 2, 2034 · High confidence	In force	Term ends Mar 2, 2034	High confidence
US 10,195,427	Method and Apparatus for Treating Sleep Apnea In force Term ends Mar 2, 2034 · High confidence	In force	Term ends Mar 2, 2034	High confidence
US 9,808,620	Method and apparatus for treating restless legs syndrome In force Term ends Jun 4, 2036 · From the USPTO record	In force	Term ends Jun 4, 2036	From the USPTO record
US 11,491,324	Adjustable devices for treating sleep apnea, and associated systems and methods In force Term ends Oct 14, 2040 · From the USPTO record	In force	Term ends Oct 14, 2040	From the USPTO record
US 11,617,888	Implantable electrodes with remote power delivery for treating sleep apnea, and associated systems and methods In force Term ends Nov 3, 2041 · From the USPTO record	In force	Term ends Nov 3, 2041	From the USPTO record
US 11,883,668	Implantable electrodes with remote power delivery for treating sleep apnea, and associated systems and methods In force Term ends Nov 3, 2041 · From the USPTO record	In force	Term ends Nov 3, 2041	From the USPTO record
US 12,397,160	Implantable electrodes with remote power delivery for treating sleep apnea, and associated systems and methods In force Term ends Nov 3, 2041 · From the USPTO record	In force	Term ends Nov 3, 2041	From the USPTO record
US 11,986,658	Implantable electrodes with remote power delivery for treating sleep apnea, and associated systems and methods In force Term ends Feb 20, 2042 · From the USPTO record	In force	Term ends Feb 20, 2042	From the USPTO record
US 11,964,154	Signal Delivery Devices to Treat Sleep Apnea, and Associated Methods and Systems In force Term ends Jun 7, 2043 · High confidence	In force	Term ends Jun 7, 2043	High confidence
US 12,741,145	Wearable Devices for Treating Sleep Apnea, and Associated Systems and Methods In force Term ends Nov 20, 2043 · High confidence	In force	Term ends Nov 20, 2043	High confidence

10 of 12 patents shown.

Pro members see all 12.

Pro members: see all 12 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro